
    
      The investigators hypothesize that Travatan Z will significantly lower intraocular pressure
      and increase ocular perfusion pressure during both the diurnal and nocturnal period, during a
      24-hour evaluation, compared to baseline. The investigators further hypothesize that the
      medication effects will persist at 72 hours after discontinuation of the drug.
    
  